BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28342810)

  • 1. Expression and putative role of mitochondrial transport proteins in cancer.
    Lytovchenko O; Kunji ERS
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):641-654. PubMed ID: 28342810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial metabolism and energy sensing in tumor progression.
    Iommarini L; Ghelli A; Gasparre G; Porcelli AM
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):582-590. PubMed ID: 28213331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VDAC in cancer.
    Mazure NM
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):665-673. PubMed ID: 28283400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection.
    Srinivasan S; Guha M; Kashina A; Avadhani NG
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):602-614. PubMed ID: 28104365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic synthetic lethality in cancer therapy.
    Zecchini V; Frezza C
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):723-731. PubMed ID: 27956047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial uncoupling in cancer cells: Liabilities and opportunities.
    Baffy G
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):655-664. PubMed ID: 28088333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of mitophagy in carcinogenesis and tumor progression.
    Chang JY; Yi HS; Kim HW; Shong M
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):633-640. PubMed ID: 28017650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and metabolic features of oncocytomas: Seeking the blueprints of indolent cancers.
    De Luise M; Girolimetti G; Okere B; Porcelli AM; Kurelac I; Gasparre G
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):591-601. PubMed ID: 28115060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer metabolism in space and time: Beyond the Warburg effect.
    Danhier P; BaƄski P; Payen VL; Grasso D; Ippolito L; Sonveaux P; Porporato PE
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):556-572. PubMed ID: 28167100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NO control of mitochondrial function in normal and transformed cells.
    Tengan CH; Moraes CT
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):573-581. PubMed ID: 28216426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitochondrial pyruvate carrier in health and disease: To carry or not to carry?
    Bender T; Martinou JC
    Biochim Biophys Acta; 2016 Oct; 1863(10):2436-42. PubMed ID: 26826034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy metabolism in skin cancers: A therapeutic perspective.
    Hosseini M; Kasraian Z; Rezvani HR
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):712-722. PubMed ID: 28161328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine transporters in mammalian cells and their functions in physiology and cancer.
    Bhutia YD; Ganapathy V
    Biochim Biophys Acta; 2016 Oct; 1863(10):2531-9. PubMed ID: 26724577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium regulates cell death in cancer: Roles of the mitochondria and mitochondria-associated membranes (MAMs).
    Danese A; Patergnani S; Bonora M; Wieckowski MR; Previati M; Giorgi C; Pinton P
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):615-627. PubMed ID: 28087257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SLC25 Carrier Family: Important Transport Proteins in Mitochondrial Physiology and Pathology.
    Kunji ERS; King MS; Ruprecht JJ; Thangaratnarajah C
    Physiology (Bethesda); 2020 Sep; 35(5):302-327. PubMed ID: 32783608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy.
    Rochette L; Meloux A; Zeller M; Malka G; Cottin Y; Vergely C
    Molecules; 2020 May; 25(10):. PubMed ID: 32455902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHTM1, a novel metabolic marker deregulated in human malignancies.
    Babbar M; Huang Y; An J; Landas SK; Sheikh MS
    Oncogene; 2018 Apr; 37(15):2052-2066. PubMed ID: 29371680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.